Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine versus trazodone for sleep quality and depression severity in major depressive disorder
IRCT20231129060218N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of quetiapine, trazodone and sertraline in major depressive disorder (MDD) (3 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoints: Sleep quality and Depression severity. Started Dec 2023; status: completed.
02
Drugs
quetiapinetrazodonesertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20231129060218N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231129060218N1.